	Peripheral blood inflammatory markers as predictive and prognostic indicators in neoadjuvant immunotherapy for non-small cell lung cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban Peng Y, Zeng Y, Zhang Y, Fan D, Wang S, Deng C, Ma F, Qiu Z, Chen C, Hu Y, Hu C, Liu W, Wu F. PMID: 42032980 [PubMed - indexed for MEDLINE]
	Empirical Osimertinib as a Second-Line Treatment Is a Viable Option Following First- and Second-Generation TKI Therapy With Unknown EGFR Status in Treated Non-Small Cell Lung Cancer: A Retrospective Study. Cancer Med Lin MH, Chu KA, Chen CF, Jiang YC, Hong WC, Hung MY, Hsu CH. PMID: 42032945 [PubMed - indexed for MEDLINE]
	First-line treatments for metastatic non-small-cell lung cancer with sugemalimab plus chemotherapy: a China-based cost-effectiveness analysis. Immunotherapy Zhang Z, Meng K, Wu M, Li A, Yi Y, Shi C, Wan X, Tan C, Jiang Z. PMID: 42032906 [PubMed - as supplied by publisher]
	Uterine angiosarcoma diagnosed solely by endometrial biopsy and the effect of oral progesterone treatment on associated lung metastases. BMJ Case Rep Abu Shamleh R, Das N, Lutchman Singh K. PMID: 42031396 [PubMed - indexed for MEDLINE]
	Pseudocellulitis in a patient with non-small cell lung cancer on carboplatin, pemetrexed and pembrolizumab. BMJ Case Rep Beadman T, Chan MM. PMID: 42031384 [PubMed - indexed for MEDLINE]
	Deulorlatinib (TGRX-326) in ALK gene fusion positive non-small cell lung cancer after failure of second-generation inhibitors (DRAGON): a single-arm, multicenter, phase 2 trial. J Thorac Oncol Huang J, Chen G, Wang Z, Jin W, Zhao Y, Zhang Y, Zhuang W, Xin Y, Wang Y, Zhou J, Sun L, Jin B, Zhang G, Yao W, Yi T, Du X, Ning F, Chang J, Guo Y, Hu Y, Wang C, Ouyang W, Cai Z, Han B, Meng R, Ding Z, Su H, Li X, Yu X, Chen M, Li G, Zhang Y, Wang J, Ma R, Gong B, Cao C, Wu B, Lei C, Cao J, Zhao Y, Zhou T, Zhao S, Huang Y, Zhang L, Yang Y. PMID: 42031067 [PubMed - as supplied by publisher]
	A delta-based multi-omics model to predict adaptive radiotherapy benefit in patients with non-small cell lung cancer during carbon-ion radiotherapy. Phys Med Biol Ju Z, Kubo N, Meng X, Sakai M, Tashiro M, Ohno T. PMID: 42031010 [PubMed - as supplied by publisher]
	SSX1 and TRIM58 expression stratifies lung squamous cell carcinoma by tumor immune microenvironment characteristics and informs potential immunotherapy responsiveness. Clin Transl Oncol Zhao X, Liu C, Sun J, Wang C, Shen Q, Zhang X, Liu D, Xie J, Yang X, Liu D. PMID: 42030005 [PubMed - as supplied by publisher]
	The Association Between Inflammatory Scores and Frailty Severity: An Exploratory Retrospective Analysis in Non-Small-Cell Lung Cancer Surgical Patients. Med Sci (Basel) Iacobescu RA, Boiculese VL, Dodi G, Lunguleac T, Grigorescu C, Antoniu S. PMID: 42029594 [PubMed - indexed for MEDLINE]
	Diagnostic Challenge of a Vascular Liver Tumor With Pulmonary Hemorrhagic Metastases: A Case Report. Cureus N P H, Edakkattu AFK. PMID: 42028496 [PubMed]
	Role of radiotherapy in the treatment of EGFR-mutant non-small-cell lung cancer: a narrative review. Ther Adv Med Oncol Wang Q, Sun F, Wu M, Liu Z, Lu S, Xiao R, Xie X, Chen M, Sun X, Xing X, Wei B, Yu J, Chen D. PMID: 42028225 [PubMed]
	Targeting TROP-2 in treatment-resistant non-small cell lung cancer harboring the KRAS G12C mutation and TROP-2 upregulation: A case report. Oncol Lett Sun L, Xiong Y, Li X, Peng Y. PMID: 42027638 [PubMed]
	A transformer-based patient-agnostic tumor motion tracking model (TransTracking): A feasibility study in radiotherapy for lung cancer. Med Phys Abuduxiku M, Chai N, An X, Li Y, Wang J, Luo Y, Wu W, Liu Y, Hu Y, Li Q, He P. PMID: 42027140 [PubMed - indexed for MEDLINE]
	Effects of Tumor Microenvironment on Lung Cancer Stem Cells: Bidirectional Regulatory Mechanisms. Cancer Med Lai H, Luo R, Zou W, Liu X, Liu M, Liu M, Zhang J. PMID: 42026778 [PubMed - indexed for MEDLINE]
	Clinical implementation and evaluation of a patient-specific surface-guided clearance mapping system for collision avoidance and noncoplanar beam planning. J Appl Clin Med Phys Wang S, Chambers E, Li R, Gonzalez Y, Zhong X, Iqbal Z, James K, Cleaton J, Sher D, Godley A, Parsons D. PMID: 42026427 [PubMed - indexed for MEDLINE]
	Risk factors for pathological invasiveness of non-mucinous invasive pulmonary adenocarcinoma with a maximum diameter of less than or equal to 3Â cm in thin-section CT: a retrospective study. Sci Rep Yang Z, He Y, Luo M, Wei J, Chu S, Xiao B, Liang Y, Xue F, Jiang W, Cai J. PMID: 42026123 [PubMed - as supplied by publisher]
	Development and Application of a Simplified Mathematical Model for The Estimation of Tumor Dose of Non-Small Cell Lung Cancer in BNCT. Int J Radiat Oncol Biol Phys Kao CF, Sheu RJ, Peir JJ, Wu YH, Chen YW, Hu YW, Jen WC, Lee JC. PMID: 42025810 [PubMed - as supplied by publisher]
	Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview. Thorac Cancer Pagliaro R, Leonardi B, Schiattarella A, Bergameo G, Picone C, D'Errico AG, Scialò F, Perrotta F, De Rimini ML, Fiorelli A, Bianco A. PMID: 42025594 [PubMed - indexed for MEDLINE]
	Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity. JCO Precis Oncol Parma M, Wang K, Altintas Taslicay C, Shah K, Singhi EK, Rivera M, Solis Soto L, Wang WL, Hong L, Li Z, Altan M, Franco Vega M, de Groot P, Halliday A, Jacome J, Zhang J, Le X, Pozadzides J, Tu J, Bueno Hume C, Blumenschein G, Skoulidis F, Cascone T, Fossella F, Vailati Negrao M, Vokes N, Gibbons D, Araujo H, Tsao A, Heymach JV, Byers LA, Gay CM, Zhang B. PMID: 42024839 [PubMed - indexed for MEDLINE]
	Radiological, Molecular, and Pathological Factors Unite: A Model for Predicting Recurrence-Free Survival in Pathological Stage I Lung Adenocarcinoma. Thorac Cancer Zeng H, Huang Y, Song Z, Yuan Z, Ren J, Xu J, Ren F, Li W, Ying J, Guo C, Tang W, Liang M, Zhang Y, Xu Q, Xue Q, Tan F. PMID: 42023991 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 159072

Page 1 of 7954



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy